PTS, Inc. Announces Two New Patents

PTS, Inc. Announces Two New Patents

Indianapolis, IN – July 10, 2013- Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek® family of point-of-care diagnostic products, has announced the issuance of two new U.S. patents. U.S. Patent No. 8,257,654 relates to the management of health data collected by point-of-care testing devices using a health report server. U.S. Patent No. 8,307,531 covers a method and apparatus for manufacturing disposable dry test strips.

“Our products are built upon a number of proprietary technologies and processes,” says Robert Huffstodt, President and CEO of PTS, Inc. “These patents, along with the other patents we hold, help PTS, Inc. maintain technological leadership for our customers.”

U.S. Patent No. 8,257,654 is for a health report server that may receive medical data from a diverse set of point-of-care testing systems deployed in a hospital or other medical facility. By utilizing a network-based system, medical data can be collected concerning patients and then securely and conveniently stored. The system allows for medical data to then be distributed to those medical personnel who need it, such as doctors. The system provides for simple menu-driven access to the stored medical information.

PTS, Inc. has led the way in providing innovative connectivity solutions. For example, the CardioChek HRA software captures biometric data and receives test results directly from a CardioChek PA analyzer to calculate a cardiac age based on an individual’s risk factors using the Framingham Heart Study criteria. And, CardioChek Link® data transfer software and cable provides for the output of test results from the CardioChek PA device into a computer spreadsheet file.

The intellectual property covered under U.S. Patent No. 8,307,531 not only provides for a more accurate test strip, but also reduces any waste and provides a more efficient manufacturing process.

The new patents are in addition to more than forty-five U.S. and international patents already owned by PTS, Inc. These patents span such technology areas as vertical flow HDL determination, room-temperature-stable triglycerides, structures and techniques for creating multi-analyte test strips, data collection and management from point-of-care testing devices, the detection of various cholesterol-related blood analytes, and other test strip-related detection technologies.

About Polymer Technology Systems, Inc. (PTS, Inc.) – Polymer Technology Systems, Inc. is a global provider of point-of-care diagnostic products to the healthcare industry.  Headquartered in Indianapolis, Indiana, PTS, Inc. designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS, Inc. products include the CardioChek PA point-of-care instrument which is marketed to the professional diagnostics industry, and the CardioChek cholesterol analyzer for consumer use. The company offers a variety of single and combination tests for lipids (cholesterols), Glucose, and Ketone, as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.cardiochek.com.

For further information, please contact:
Laura Wilkerson
Director of Marketing
Polymer Technology Systems, Inc.
7736 Zionsville Road
Indianapolis, IN 46268
317-870-5610

All trademarks used or mentioned in this release are protected by law.

LIT 001581 Rev. 0 06/13

PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time

PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time

Indianapolis, IN – August 21, 2013- For the third time, Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of the CardioChek® family of point-of-care diagnostic products, has been named to the 2013 Inc. 500|5000 list of the fastest-growing private companies in America. The Inc. 5000 is ranked according to percentage revenue growth over a four-year period.

PTS, Inc. joins the elite ranks of companies like Microsoft, Timberland, Vizio, Intuit, Jamba Juice, Oracle, and Zappos.com who have made the list three or more times in their history. “We’re delighted and honored to be named to the list for a third time,” says Robert Huffstodt, President and CEO of PTS, Inc. “Our company continues to grow rapidly because of the quality solutions we’re able to provide for our customers.”

PTS, Inc.’s 60% growth also puts the company 61st in the “Top 100 Indiana Companies” listing, according to Inc.com.

PTS, Inc. recently introduced the CardioChek Plus analyzer which delivers rapid test results for lipids and glucose simultaneously. “We focus our efforts on bringing innovative technologies that can help our customers improve health for people around the world,” says Huffstodt. “Ultimately, our products help people live healthier lives by offering healthcare providers and their patients immediate feedback on important health parameters.”

About Polymer Technology Systems, Inc. (PTS, Inc.) – Polymer Technology Systems, Inc. is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America and the Pacific Rim. PTS, Inc. products include the CardioChek PA point-of-care instrument which is marketed to the professional diagnostics industry, the CardioChek cholesterol analyzer for consumer use, and soon the newly-introduced CardioChek Plus analyzer. The company offers a variety of single and combination tests for lipids (cholesterols), glucose, and ketones, as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.cardiochek.com.

For further information, please contact:
Laura Wilkerson
Director of Marketing
Polymer Technology Systems, Inc.
7736 Zionsville Road
Indianapolis, IN 46268
317-870-5610

About Inc. 5000 – Now in its seventh year, the Inc. 5000 is the most comprehensive portrait of America’s fastest-growing private companies assembled anywhere. Each profile is reported by one of the dozens of writers assigned to the project. Many firms are innovators with little coverage elsewhere; many others are using their cutting-edge savvy to grown their market share in traditional products and services, and are similarly underreported by the rest of the business media. The Inc. 5000 profiles are available on Inc.com.

All trademarks used or mentioned in this release are protected by law.

SOURCE Polymer Technology Systems, Inc. 
LIT 001589 Rev. 0 08/13

PTS, Inc. Acquires A1CNow and Expands Product Portfolio

PTS, Inc. Acquires A1CNow and Expands Product Portfolio

Indianapolis, IN – December 20, 2013- Polymer Technology Systems, Inc. (PTS, Inc.), the U.S. based manufacturer of the CardioChek family of Point-of-Care diagnostic products, announced today that it has acquired the A1CNow family of products from Bayer Diabetes Care. The A1CNow+® Multi-test A1C System and A1CNow® SELFCHECK At-Home A1C System are important testing devices for readily monitoring A1C levels. The tests provide healthcare providers and people with diabetes with an indicator of the patient’s average blood glucose control over approximately the past 3 months.

“We’re very excited about the addition of the A1CNow system to the PTS product portfolio,” says Robert Huffstodt, President and CEO of PTS, Inc. “There is an established relationship between A1c levels, lipid levels and the risk for complications of diabetes, and the A1CNow products are important tools in helping providers and patients understand how well their diabetes treatment plan is working.”

The A1CNow acquisition strengthens the PTS product portfolio by adding testing capabilities that are being requested by many current PTS customers. The A1CNow system’s rapid results and mobility features enable healthcare providers to communicate face-to-face with patients about their diabetes control thus, providing optimum Point-of-Care convenience.

“We believe this acquisition is good news for PTS customers and A1CNow customers alike,” explains Huffstodt. “We’re eager to begin providing A1CNow systems to our global markets as soon as possible to help deliver vital information for healthcare providers and people with diabetes around the world.” Manufacturing will continue at the current plant in Sunnyvale, CA and product availability details will be forthcoming.

About Polymer Technology Systems, Inc. (PTS, Inc.) – Polymer Technology Systems, Inc. is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America and the Pacific Rim. PTS, Inc. products include the CardioChek PA Point-of-Care instrument which is marketed to the professional diagnostics industry, the CardioChek cholesterol analyzer for consumer use, and now the new CardioChek Plus analyzer. The company offers a variety of single and combination tests for lipids (cholesterols), glucose, and ketones as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.cardiochek.com. For further information, please contact:

Laura Wilkerson
Director of Marketing
Polymer Technology Systems, Inc.
7736 Zionsville Road
Indianapolis, IN 46268
317-870-5610

All trademarks used or mentioned in this release are protected by law.

SOURCE Polymer Technology Systems, Inc.
LIT 001610 Rev. 0 12/13

PTS Diagnostics Now Shipping A1CNow®+ Systems

PTS Diagnostics Now Shipping A1CNow®+ Systems

Indianapolis, IN – May 6, 2014- PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow family of point-of-care diagnostic products, announced today that they have started shipping A1CNow+ systems to their distributor network. Just four months ago, PTS Diagnostics acquired the A1CNow family of products from Bayer Diabetes Care.

“A1CNow systems are important to healthcare providers and patients worldwide,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “So, it was critical for us to facilitate a seamless transition and deliver the products in a timely manner.”

Ben Irvin, Director of A1CNow Research and Development, was a member of the team that developed the original A1CNow system in the early 2000s. “All of us in Sunnyvale, CA, are excited to be part of PTS Diagnostics. Their expertise in diagnostic device manufacturing, scientific knowhow, and established distribution network make this affiliation a perfect fit for the A1CNow family of products. We are also pleased that we were able to retain over 50 of our key people and that manufacturing and development will continue at the current plant in Sunnyvale.”

Not only did PTS Diagnostics acquire a high-quality and well-known product family, the company also purchased a proven manufacturing facility and is pleased to also employ so many associates that have a deep institutional knowledge of the A1CNow technology.

“We are delighted to welcome these former Bayer A1CNow employees and their customers to the PTS Diagnostics family. This has been an extraordinarily fast and easy transition. We are proud to be shipping product this quickly,” Huffstodt continued. “We know there is significant pent-up demand for the A1CNow+, and are pleased to be able to provide product without further delay.”

A1CNow+ empowers healthcare professionals to provide individuals with an indicator of average blood glucose control for the past 2 to 3 months.

About PTS Diagnostics – PTS Diagnostics is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS Diagnostics’ products include the CardioChek systems and A1CNow point-of-care systems. The company also offers a variety of single and combination tests for lipids (cholesterols), glucose, and ketones, as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.ptsdiagnostics.com or contact Laura Wilkerson at 317-870-5610.

All trademarks used or mentioned in this release are protected by law.

MKG001345 Rev. 0 03/15

PTS Diagnostics Now Providing eHealthScreenings with Fast Lipid (Cholesterol) and Glucose Screening Devices

PTS Diagnostics Now Providing eHealthScreenings with Fast Lipid (Cholesterol) and Glucose Screening Devices

Indianapolis, IN– June 10, 2014- PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, announced today that they have signed an agreement to provide their CardioChek Plus analyzers and lipid panel test strips to eHealthScreenings, a leading provider of onsite comprehensive wellness screening services.

Clients of eHealthScreenings include third-party administrators, employee assistance programs, human resources consultants, insurance providers, and wellness companies.

“We are excited to begin using the CardioChek system,” said Jason Morgese, President of eHealthScreenings. “We needed to make a switch to an analyzer that could provide lipid panel results faster, and after thorough evaluation of the available solutions, it was clear to us that the CardioChek analyzers delivered the speed that we need for large-scale on-site screenings.”

eHealthScreenings will use the CardioChek Plus, a cost-efficient, user-friendly diagnostic point-of-care analyzer that provides rapid on-site lipid panel plus glucose screenings. The capability to deliver both results in as little as 90 seconds enables healthcare professionals to screen more individuals faster. Offering simultaneous testing of a lipid profile (total cholesterol, HDL cholesterol, triglycerides) and glucose, the CardioChek Plus analyzer also calculates LDL cholesterol, TC/HDL ratio, LDL/HDL ratio, and non-HDL cholesterol. The CardioChek Plus device requires only a small blood sample from a fingerstick.

“We are proud to partner with eHealthScreenings,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “As leaders in onsite testing for major organizations, they are among the companies that are changing the way modern healthcare is delivered. Their efforts positively impact the lives of many individuals, which is the essence of our mission.”

“Our services save organizations significant healthcare expense, but helping people identify ways to improve their health is the most important thing we do,” continued Morgese. “The CardioChek systems are fast and easy to use; they don’t require refrigeration and they are battery-operated, which are all important operational benefits for our teams.”

“Our switch to PTS Diagnostics’ CardioChek system advances our mission considerably,” concluded Morgese.

About eHealthScreenings – As the nation’s leading provider of comprehensive wellness screening services, and one of the only true companies specifically centered on biometric screenings, eHealthScreenings focuses all their resources on optimizing screening technology, service levels, incredible customer support, and simplification of the process. With multiple dedicated teams, a network of 200 affiliated office locations, and thousands of nationwide lab locations, eHealthScreenings is focused on perfecting the screening model and experience for clients such as third party administrators, employee assistance programs, human resources consultants, insurance providers, and wellness companies. Their home office is in San Antonio, Texas. For more information, visit https://www.ehealthscreenings.com.

About PTS Diagnostics – PTS Diagnostics is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS Diagnostics’ products include both the CardioChek systems and A1CNow point-of-care systems. The company also offers a variety of single and combination tests for lipids (cholesterols), glucose, and ketones, as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.ptsdiagnostics.com or contact Laura Wilkerson at 317-870-5610.

All trademarks used or mentioned in this release are protected by law.

SOURCE: PTS Diagnostics
MKG001346 Rev.0 03/15